Pityriasis rubra pilaris: A review of diagnosis and treatment

American Journal of Clinical Dermatology

Volumn 11, Issue 3, 2010, Pages 157-170

  Klein, Annette ^a   Landthaler, Michael ^a   Karrer, Sigrid ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Acitretin; Adalimumab; Antiretrovirals; Azathioprine; Calcipotriol; Children; Ciclosporin; Corticosteroids; Efalizumab; Therapeutic use

Indexed keywords

ADALIMUMAB; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN A; EFALIZUMAB; EMOLLIENT AGENT; ETRETIN; ETRETINATE; FUMARIC ACID; IMMUNOGLOBULIN; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; RETINOIC ACID; RETINOID; RETINOL; SALICYLIC ACID; STANOZOLOL; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UREA;

ACANTHOLYTIC DYSKERATOSIS; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ECTROPION; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KERATODERMA; LIVER TOXICITY; LOW DRUG DOSE; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET RADIATION;

ADMINISTRATION, TOPICAL; BIOPSY; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PITYRIASIS RUBRA PILARIS; SKIN;

EID: 77950688728     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11530070-000000000-00000     Document Type: Review

References (122)

1. Devergie MGA. Pityriasis pilaris, maladie de peau non décrite par les dermatologistes. Gazette Hebdomadaire de médicine et de chirurgie 1856; 3: 197-201
2. Besnier E. Observations pour servir à l'histoire clinique du pityriasis rubra pilaire. Ann Derm Syph Ser 1889; 10: 253-287
3. Griffiths WAD, Ozluer S. Pityriasis rubra pilaire. Ann Dermatol Venereol 2001; 128: 931-934
4. Griffiths WAD. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5: 105-112
5. Rinker MH, Shenefelt PD. Pityriasis rubra pilaris [online]. Available from URL: http://www.emedicine.com/DERM/topic337.htm/ [Accessed 2008 Nov 1]
6. Coras B, Vogt T, Ulrich H, et al. Fumaric acid esters therapy: a new treatment modality in pityriasis rubra pilaris? Br J Dermatol 2005; 152: 388-389
7. Griffiths WAD. Pityriasis rubra pilaris: an historical approach. 2. Clinical features. Clin Exp Dermatol 1976; I: 37-50
8. Allison DS, el-Azhary R, Calobrisi SD, et al. Pityriasis rubra pilaris in children. J Am Acad Dermatol 2002; 47: 386-389
9. Dicken CH. Treatment of classic pityriasis rubra pilaris. JAmAcad Dermatol 1994; 31: 997-999
10. Albert MR, Mackool BT. Pityriasis rubra pilaris. Int J Dermatol 1999; 38: 1-11
11. Piamphongsant T, Akaraphant R. Pityriasis rubra pilaris: a new proposed classification. Clin Exp Dermatol 1994; 19: 134-138
12. Griffiths A. Pityriasis rubra pilaris: etiologic considerations. J Am Acad Dermatol 1984; 10: 1086-1088
13. Kurzydlo A-M, Gillespie R. Paraneoplastic pityriasis rubra pilaris in association with bronchogenic carcinoma. Australas J Dermatol 2004; 45: 130-132
14. Martinez Calixto LE, Suresh L, Matsumura E, et al. Oral pityriasis rubra pilaris. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 604-607
15. Paranjothy B, Shunmugam M, MacKenzie J, et al. Peripheral ulcerative keratitis in pityriasis rubra pilaris. Eye 2007; 21: 1001-1002
16. Braun-Falco O, Ryckmanns F, Schmoeckel C, et al. Pityriasis rubra pilaris: a clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy. Arch Dermatol Res 1983; 275: 287-295
17. Karneva L, Lauharanta J, NiemiK-M, et al. Ultrastructure of pityriasis rubra pilaris with observations during retinoid (etretinate) treatment. Br J Dermatol 1983; 108: 653-663
18. Hashimoto K, Fedoronko L. Pityriasis rubra pilaris with acantholysis and lichenoid histology. Am J Dermatopathol 1999; 21: 491-493
19. Hoover W, Maize JC. Focal acantholytic dyskeratosis occurring in pityriasis rubra pilaris. Am J Dermatopathol 1990; 12: 321-323
20. Howe K, Foresman P, Griffin T, et al. Pityriasis rubra pilaris with acantholysis. J Cutan Pathol 1996; 23: 270-274
21. Tannenbaum CB, Billick RC, Srolovitz H. Multiple cutaneous malignancies in a patient with pityriasis rubra pilaris and focal acantholytic dyskeratosis. J Am Acad Dermatol 1996; 35: 781-782
22. Magro CM, Crowson AN. The clinical and histomorphological features of pityriasis rubra pilaris. J Cutan Pathol 1997; 24: 416-424
23. Barr RF, Young EM. Psoriasiform and related papulosquamous disorders. J Cutan Pathol 1985; 12: 412-425
24. Soeprono FF. Histologic criteria for the diagnosis of pityriasis rubra pilaris. Am J Dermatopathol 1986; 8: 277-283
25. Sehgal VN, Srivastav G. (Juvenile) pityriasis rubra pilaris. Int J Dermatol 2006; 45: 438-446
26. Caldarola G, Zampetti A, De Simone C, et al. Circumscribed pityriasis rubra pilaris type IV. Clin Exp Dermatol 2007; 32: 471-472
27. Gelmetti G, Schiuma AA, Cerri D, et al. Pityriasis rubra pilaris in childhood: a long-term study of 29 cases. Pediatr Dermatol 1986; 3: 446-451
28. Vanderhooft SL, Francis J. Familial pityriasis rubra pilaris. Arch Dermatol 1995; 131: 448-453
29. Thomson MA, MossC. Pityriasis rubra pilaris in amother and two daughters. Br J Dermatol 2007; 157: 202-204
30. Miralles ES, Nú ñez M, De Las Heras ME, et al. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol 1995; 133: 990-993
31. González-Ló pez A, Velasco E, Pozo T, et al. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. Br J Dermatol 1999; 140: 931-934
32. Auffret N, Quint L, Domart P, et al. Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27: 260-261
33. Resnick SD, Murrell DF, Woosley JT. Pityriasis rubra pilaris, acne conglobata, and elongated follicular spines: an HIV-associated syndrome? J Am Acad Dermatol 1993; 29: 283
34. Shahidullah H, Aldridge RD. Changing forms of juvenile pityriasis rubra pilaris: a case report. Clin Exp Dermatol 1994; 19: 254-256
35. Griffiths WA. Pityriasis rubra pilaris: the problem of its classification. J Am Acad Dermatol 1992; 26: 140-142
36. Arnold AW, Buechner SA. Circumscribed juvenile pityriasis rubra pilaris. J Eur Acad Dermatol Venereol 2004; 18: 705-707
37. LarrègueM, Champion R, Bressieux JM, et al. Acute pityriasis rubra pilaris in the child: apropos of 4 cases. Ann Derm Venereol 1983; 110: 221-228
38. Betloch I, Ramó nR, Silvestre J-F, et al. Acute juvenile pityriasis rubra pilaris: a superantigen mediated disease? Pediatr Dermatol 2001; 18: 411-414
39. Möhrenschlager M, Abeck D. Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two cases. Pediatr Dermatol 2002; 19: 569
40. Al-Dhalimi MA. Neonatal and infantile erythema: a clinical and follow-up study of 42 cases. J Dermatol 2007; 34: 302-307
41. Hong JB, Chiu HC, Wang SH, et al. Recurrence of classical juvenile pityriasis rubra pilaris in adulthood: report of a case. Br J Dermatol 2007; 157: 842-844
42. Menni S, Brancaleone W, Grimalt R. Pityriasis rubra pilaris in a child seropositive for the human immunodeficiency virus. J Am Acad Dermatol 1992; 27: 1009
43. Chan H, Liu FT, Naguwa S. A review of pityriasis rubra pilaris and rheumatologic associations. Clin Dev Immunol 2004; 11: 57-60
44. Karimian-Teherani D, Parissa M, Tanew A. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment. Pediatr Dermatol 2008; 25: 125-126
45. Sehgal VN, Srivastava G, Dogra S. Adult onset pityriasis rubra pilaris. Indian J Dermatol Venereol Leprol 2008; 74: 311-321
46. Baran W, Szepietowski JC, Szybejko-Machaj G. Enhanced expression of p53 in pityriasis rubra pilaris. Acta Derm Venereol 2006; 86: 276-277
47. Finzi AF, Altomare G, Bergamaschini L, et al. Pityriasis rubra pilaris and retinol-binding protein. Br J Dermatol 1981; 104: 253-256 (Pubitemid 11060736)
48. Griffiths WAD. Vitamin A and pityriasis rubra pilaris [letter]. J Am Acad Dermatol 1982; 7: 555
49. Kawara S, Miyake M, Oiso N, et al. Pityriasis rubra pilaris with preceding cytomegalovirus infection. Dermatology 2009; 219: 350-352
50. Ertam I, Sezgin AO, Kazandi A, et al. A case of juvenile pityriasis rubra pilaris: could varicella be an aetiological agent? Clin Exp Dermatol 2009; 34: e1012-3
51. De D, Dogra S, Narang T, et al. Pityriasis rubra pilaris in a HIV-positive patient (type 6 PRP). Skinmed 2008; 7: 47-50
52. Sá nchez-Regaña M, Fuentes CG, Creus L, et al. Pityriasis rubra pilaris and HIV infection: a part of the spectrum ofHIV-associated follicular syndrome. Br J Dermatol 1995; 133: 814-821
53. Misery L, Faure M, Claudy A. Pityriasis rubra pilaris and human immunodeficiency virus infection: type 6 pityriasis rubra pilaris? Br JDermatol 1996; 135: 1008-1009
54. Castanet J, Lacour JP, Perrin C, et al. Juvenile pityriasis rubra pilaris associated with hypogammaglobulineaemia and furunculosis. Br JDermatol 1994; 131: 717-719
55. Shvili D, DavidM,Mimouni M. Childhood-onset pityriasis rubra pilaris with immunologic abnormalities. Pediatr Dermatol 1987; 4: 21-23
56. Hazini AR, Rongioletti F, Rebora A. Pityriasis rubra pilaris and vitiligo in Down's syndrome. Clin Exp Dermatol 1988; 13: 334-335
57. Holden CA, Curley RK. Down's syndrome and pityriasis rubra pilaris. Clin Exp Dermatol 1989; 14: 332
58. Terasaki K, Kanekura T, Saruwatari H, et al. Classical juvenile pityriasis rubra pilaris in a patient with Down syndrome. Clin Exp Dermatol 2004; 29: 49-51
59. Batchelor RJ, Yung A, Merchant W, et al. Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma? Clin Exp Dermatol 2005; 30: 442-443
60. Huynh NT, Hunt MJ, Cachia AR, et al. Merkel cell carcinoma and multiple cutaneous squamous cell carcinomas in a patient with pityriasis rubra pilaris. Australas J Dermatol 2002; 45: 48-51
61. Kloos C, Müller UA, Höffken K, et al. Paraneoplastic pityriasis rubra pilaris in metastatic adenocarcinoma without diagnosable primary. Dtsch Med Wochenschr 2002; 127: 437-440
62. Sharma S, Weiss GR, Paulger B. Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma. Dermatology 1997; 194: 166-167
63. Batinac T, Kujundzic M, Peternel S, et al. Pityriasis rubra pilaris in association with laryngeal carcinoma. Clin Exp Dermatol 2009; 34: e917-9
64. Sánchez-RegañaM, Ló pez-Gil F, Salleras M, et al. Pityriasis rubra pilaris as the initial manifestation of internal neoplasia. Clin Exp Dermatol 1995; 20: 436-438
65. Sahin MT, Öztürkcan S, Türel Ermertcan A, et al. Transient eruptive seborrhoeic keratoses associated with erythrodermic pityriasis rubra pilaris. Clin Exp Dermatol 2004; 29: 554-555
66. Gleeson CM, Chan I, Griffiths WA, et al. Eruptive seborrhoeic keratoses associated with erythrodermic pityriasis rubra pilaris. J Eur Acad Dermatol Venereol 2009; 23: 217-218
67. Cohen PR, Prystowsky JH. Pityriasis rubra pilaris: a review of diagnosis and treatment. J Am Acad Dermatol 1989; 20: 802-807
68. Behr FD, Bangert JL, Hansen RC. Atypical pityriasis rubra pilaris associated with arthropathy and osteoporosis: a case report with 15-year follow-up. Pediatr Dermatol 2002; 19: 46-51
69. Fiallo P, Tagliapietra AG, Santoro G. Arthropathic pityriasis rubra pilaris. Br J Dermatol 1996; 134: 1154-1155
70. Conaghan PG, Sommer S, McGonagle D, et al. The relationship between pityriasis rubra pilaris and inflammatory arthritis. Arthritis Rheum 1999; 42: 1998-2001
71. Lister RK, Perry JD, Cerio R. Pityriasis rubra pilaris and a seronegative polyarthritis. Br J Dermatol 1997; 137: 318-319
72. Nakafusa J, Misago N, NarisawaY. Pityriasis rubra pilaris in associationwith polyarthritis. Dermatology 2002; 205: 298-300
73. Gül Ü, Gönül M, KiliçA. A case of pityriasis rubra pilaris associated with sacroileitis and autoimmune thyroiditis. J Eur Acad Dermatol Venereol 2008; 22: 889-890
74. Caporali R, Cavagna L, Bellosta M. Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of Wongs's dermatomyositis. Clin Rheumatol 2004; 23: 63-65
75. Requena L, Grilli R, Soriano L, et al. Dermatomyositis with a pityriasis rubra pilaris-like eruption: a little-known distinctive cutaneous manifestation of dermatomyositis. Br J Dermatol 1997; 136: 768-771
76. Polat M, Lenk N, Üstün H, et al. Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis. Pediatr Dermatol 2007; 24: 151-154
77. Rasi A, Soltani-Arabshahi R, Naraghi ZS. Circumscribed juvenile-onset pityriasis rubra pilaris with hypoparathyroidism and brachyonychia. Cutis 2006; 77: 218-222
78. Orlandini V, Cogrel O, Doutre MS, et al. Pityriasis rubra pilaris and hypothyroidism: efficacy of thyroid hormone replacement therapy in skin recovery. Br J Dermatol 2007; 156: 606-607
79. Selvaag E, Haedersdal M, Thomsen K. Pityriasis rubra pilaris: a retrospective study of 12 patients. J Eur Acad Dermatol Venereol 2000; 14: 514-515
80. Van De Kerkhof PCM, Steijlen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994; 130: 675-678
81. Gregoriou S, Argyriou G, Christofidou E, et al. Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%. J Drugs Dermatol 2007; 6: 340-342
82. Van Dooren-Greebe RJ, Van De Kerkhof PCM. Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris. J Am Acad Dermatol 1995; 32: 322-325
83. Kirby B, Watson R. Pityriasis rubra pilaris treated with acitretin and narrowband ultraviolet B (Re-TL-01). Br J Dermatol 2000; 142: 376
84. Wetzig T, Sticherling M. Juvenile pityriasis rubra pilaris: successful treatment with ciclosporin. Br J Dermatol 2003; 149: 202-203
85. Cox V, Lesesky EB, Garcia BD, et al. Treatment of juvenile pityriasis rubra pilaris with etanercept. J Am Acad Dermatol 2009; 59: S113-4
86. Walling HW, Swick BL. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch Dermatol 2009; 145: 99-101
87. GómezM,RuelasME, WelshO. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient. J Drugs Dermatol 2007; 3: 337-339
88. Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol 1982; 6: 710-715
89. Borok M, Lowe NJ. Pityriasis rubra pilaris: further observations of systemic retinoid therapy. J Am Acad Dermatol 1990; 22: 792-795
90. Clayton BD, Jorizzo JL, Hichcock MG, et al. Adult pityriasis rubra pilaris: a 10-year case series. J Am Acad Dermatol 1997; 36: 959-964
91. Rosenbach A, Lowe NJ. Pityriasis rubra pilaris and cyclosporine. Arch Dermatol 1993; 129: 1346-1348
92. Usuki K, SekiyamaM, Shimada T, et al. Three cases of pityriasis rubra pilaris successfully treated with cyclosporin A. Dermatology 2000; 200: 324-327
93. Herbst RA, Vogelbruch AE, Kiehl P, et al. Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris. Br J Dermatol 2000; 142: 574-575
94. Neess CM, HinrichsR,Dissemond J, et al. Treatment of pruritus by capsaicin in a patient with pityriasis rubra pilaris receiving RE-PUVA therapy. Clin Exp Dermatol 2000; 25: 209-211
95. Haenssle HA, Bertsch HP, Emmert S, et al. Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris. Clin Exp Dermatol 2004; 29: 244-246
96. Hofer A, Mullegger R, Kerl H, et al. Extracorporeal photochemotherapy for the treatment of erythrodermic pityriasis rubra pilaris. Arch Dermatol 1999; 135: 475-476
97. Kerr AC, Ferguson J. Type II adult-onset pityriasis rubra pilaris successfully treated with intravenous immunoglobulin. Br J Dermatol 2007; 156: 1055-1056
98. Liao WC, Mutasim DF. Infliximab for the treatment of adult-onset pityriasis rubra pilaris. Arch Dermatol 2005; 141: 423-425
99. Manoharan S, White S, Gumparthy K. Successful treatment of type I adultonset pityriasis rubra pilaris with infliximab. Australas J Dermatol 2006; 47: 124-129
100. Drosou A, Kirsner RS, Welsh E, et al. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 2003; 7: 382-386
101. Ruiz-Genao DP, Lopez-Estebaranz JL, Naz-Villalba E, et al. Pityriasis rubra pilaris successfully treated with infliximab. Acta Derm Venereol 2007; 87: 552-553
102. Ruzzetti M, Saraceno R, Carboni I, et al. Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. J Eur Acad Dermatol Venereol 2008; 22: 117-118
103. Lu R, George SJ, Hsu S. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab. Dermatol Online J 2006; 12: 18
104. Müller H, Gattringer C, Zelger B, et al. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. J Am Acad Dermatol 2008; 59: 65-70
105. Davis KF, Wu JJ, Murase JE, et al. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch Dermatol 2007; 143: 1597-1599
106. Seckin D, Tula E, Ergun T. Successful use of etanercept in type I pityriasis rubra pilaris. Br J Dermatol 2007; 158: 642-643
107. Fanti PA, Dika E, Vaccari S, et al. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 2006; 45: 1464-1465
108. Yang FC, Jessup C,Dahiya M, et al. Pityriasis rubra pilaris exacerbation with topical use of imiquimod. Int J Dermatol 2008; 47: 1076-1078
109. Terheyden P, Hofmann UB, Hamm H, et al. Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children: diagnosis: pityriasis rubra pilaris, classic juvenile type. Hautarzt 2001; 52: 1058-1061
110. Rosinska D, Wolska H, Jablonska S, et al. Etretinate in severe psoriasis of children. Pediatr Dermatol 1988; 4: 266-272
111. Arbegast KD, Braddock SW, Lamberty LF, et al. Treatment of infantile cystic acne with oral isotretinoin: a case report. Pediatr Dermatol 1991; 8: 166-168
112. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003; 49: 171-182
113. Abbott RA, Griffiths WA. Pityriasis rubra pilaris type I spontaneously resolving after 20 years. Clin Exp Dermatol 2009; 34: 378-379
114. Kaskel P, Kollmann-Grundmann M, Schiller PI, et al. Bath-PUVA as treatment for pityriasis rubra pilaris provoked by ultraviolet B. Br J Dermatol 1999; 140: 769-770
115. Evangelou G, Murdoch SR, Palamaras I, et al. Photoaggravated pityriasis rubra pilaris. Photodermatol Photoimmunol Photomed 2005; 21: 272-274
116. Iredale HE, Meggitt SJ. Photosensitive pityriasis rubra pilaris. Clin Exp Dermatol 2005; 31: 36-38
117. Yaniv R, Barzilai A, Trau H. Pityriasis rubra pilaris exacerbated by ultraviolet B phototherapy. Dermatology 1994; 189: 313
118. Davidson Jr CL, Winkelmann RK, Kierland RR. Pityriasis rubra pilaris: a follow-up study of 57 patients. Arch Dermatol 1969; 100: 175-178
119. Durairaj VD, Horsley MB. Resolution of pityriasis rubra pilaris-induced cicatricial ectropionwith systemic low-dosemethotrexate.AmJOphthalmol 2007; 143: 709-710
120. Barth D, Harth W, Treudler R, et al. Successful treatment of pityriasis rubra pilaris (type I) under combination of infliximab and methotrexate. J Dtsch Dermatol Ges 2009; 7: 1071-1073
121. Schreml S, Zeller V, Babilas P, et al. Pityriasis rubra pilaris successfully treated with adalimumab. Clin Exp Dermatol. In press
122. Klein A, Szeimies RM, Landthaler M, et al. Exacerbation of pityriasis rubra pilaris under efalizumab therapy. Dermatology 2007; 215: 72-75